Overview
Biotech
AI-driven psychedelic drug design using their Osmanthus platform. Lead compound MSD-001 (5-MeO-MiPT) in Phase 1 trials for mental health disorders. $24M+ raised.
Visit Website0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record